U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5169151691Metacognitive Therapy Versus Cognitive Behavioral Therapy for Mixed Anxiety Disorders: A Randomized Controlled Trial.Active, not recruitingNo Results AvailableMixed Anxiety DisordersBehavioral: Metacognitive therapy|Behavioral: Cognitive behavioral therapyhttps://ClinicalTrials.gov/show/NCT01889342
5169251692Development and Field Testing of Ready-to-use-therapeutic Foods Made of Local Ingredients in Bangladesh for SAM ChildrenRecruitingNo Results AvailableSevere Acute Malnutrition in ChildhoodDietary Supplement: RUTF-1|Dietary Supplement: RUTF-2|Dietary Supplement: Plumpynuthttps://ClinicalTrials.gov/show/NCT01889329
5169351693Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared MethodCompletedNo Results AvailableLabor Fetal AnoxiaDevice: Novii|Device: AN24https://ClinicalTrials.gov/show/NCT01889316
5169451694Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric CancerRecruitingNo Results AvailableGastric CancerDrug: DC|Drug: concurrent chemoradiotherapy with 5-FU/CF|Radiation: adjuvant radiationhttps://ClinicalTrials.gov/show/NCT01889303
5169551695Methylnaltrexone Pharmacokinetics in Neurointensive Care PatientsRecruitingNo Results AvailableOpioid Use, Unspecified With Other Opioid-induced DisorderDrug: Methylnaltrexonehttps://ClinicalTrials.gov/show/NCT01889290
5169651696Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic NephropathyCompletedNo Results AvailableDiabetic NephropathyDrug: MT-3995-Low|Drug: MT-3995-High|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01889277
5169751697Methionine Metabolism in Enterally Fed Pediatric SepsisRecruitingNo Results AvailableSepsis|Critical IllnessOther: Observationalhttps://ClinicalTrials.gov/show/NCT01889264
5169851698A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular AdhesionCompletedNo Results AvailableVitreomacular AdhesionDrug: A01016|Drug: Sham injectionhttps://ClinicalTrials.gov/show/NCT01889251
5169951699Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerActive, not recruitingNo Results AvailableAdvanced, Androgen Receptor Positive Triple Negative Breast CancerDrug: Enzalutamidehttps://ClinicalTrials.gov/show/NCT01889238
5170051700Obesity and MortalityCompletedNo Results AvailableObesity and Overweighthttps://ClinicalTrials.gov/show/NCT01889225
5170151701Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLCTerminatedNo Results AvailableLung CancerOther: 11C-erlotinib PET/CThttps://ClinicalTrials.gov/show/NCT01889212
5170251702Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS WomenRecruitingNo Results AvailablePolycystic Ovary Syndrome (PCOS)Drug: Flutamidehttps://ClinicalTrials.gov/show/NCT01889199
5170351703A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p DeletionActive, not recruitingNo Results AvailableChronic Lymphocytic Leukemia|17 p Deletion|Cancer of the Blood and Bone MarrowDrug: ABT-199https://ClinicalTrials.gov/show/NCT01889186
5170451704Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy AdultsCompletedNo Results AvailableHealthy AdultsDrug: TNX-102 SL Tablets at 2.8 mg|Drug: TNX-102-B SL Tablets at 2.8 mg|Drug: TNX-102-C SL Tablets at 2.8 mg|Drug: Cyclobenzaprine tabletshttps://ClinicalTrials.gov/show/NCT01889173
5170551705Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose LevelsCompletedNo Results AvailableSafety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and TmaxDrug: AZD4721 Solution|Drug: AZD4721 Placebo|Drug: AZD4721 Suspensionhttps://ClinicalTrials.gov/show/NCT01889160
5170651706Microdose and First-In-Human (FIH) Study of Recombinant Human Placental Alkaline Phosphatase (hRESCAP)CompletedNo Results AvailableHealthyBiological: hRESCAP|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01889147
5170751707OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary HyperparathyroidismCompletedNo Results AvailablePrimary HyperparathyroidismDrug: Sedron (alendronate)|Procedure: Parathyroidectomyhttps://ClinicalTrials.gov/show/NCT01889134
5170851708Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their MothersCompletedNo Results AvailableNeonatal Abstinence SyndromeBehavioral: Structured psychosocial interventionhttps://ClinicalTrials.gov/show/NCT01889121
5170951709Feasibility Study of SPEEDICompletedNo Results AvailablePrematureBehavioral: SPEEDIhttps://ClinicalTrials.gov/show/NCT01889108
5171051710Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic PatientsCompletedNo Results AvailableDiabetes Type 2Drug: BIAsp 30|Drug: NPH/Reghttps://ClinicalTrials.gov/show/NCT01889095
5171151711Recruiting and Retaining Young Adults in Behavioral Weight Loss TreatmentCompletedNo Results AvailableObesityBehavioral: Behavioral Weight Loss Intervention for Young Adultshttps://ClinicalTrials.gov/show/NCT01889082
5171251712A Study to Evaluate Safety, Efficacy and Pharmacokinetics of MabThera/Rituxan (Rituximab) in Patients With Diffuse Large B Cell Lymphoma or Follicular LymphomaActive, not recruitingNo Results AvailableLymphomaDrug: MabThera/Rituxan|Drug: Standard chemotherapyhttps://ClinicalTrials.gov/show/NCT01889069
5171351713Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in HumansActive, not recruitingNo Results AvailableHealthyDrug: Erythropoietin (Epoetin beta)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01889056
5171451714Monitoring of Non-invasive Ventilation During Sleep in ALSActive, not recruitingNo Results AvailableAmyotrophic Lateral Sclerosishttps://ClinicalTrials.gov/show/NCT01889043
5171551715Cardiovascular Risk Stratification of Ambulatory Patients in Primary PreventionCompletedNo Results AvailableCardiovascular Primary Preventionhttps://ClinicalTrials.gov/show/NCT01889030
5171651716Generic Immunosuppressive Drugs After Lung TransplantationRecruitingNo Results AvailableImmunosuppressive After Lung TransplantationOther: patient questionnaire (tablet pc based)https://ClinicalTrials.gov/show/NCT01889017
5171751717The Neural Mechanisms of Anesthesia and Human ConsciousnessRecruitingNo Results AvailableConsciousness, Level AlteredDrug: Dexmedetomidine|Drug: Propofolhttps://ClinicalTrials.gov/show/NCT01889004
5171851718Substrate Oxidation Does Not Affect Short Term Food Intake in Healthy Boys and MenCompletedNo Results AvailableFood Intake Regulation|Substrate OxidationOther: Glucose Preload and Exercise Interventionhttps://ClinicalTrials.gov/show/NCT01888991
5171951719Molecularly Tailored Therapy for Pancreas CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: Gem-OX|Drug: Gem-5FU|Drug: Gem-Tax|Drug: Modified FOLFOX-6|Drug: Ox-Tax|Drug: FOLFIRI|Drug: Tax-Irihttps://ClinicalTrials.gov/show/NCT01888978
5172051720Maintenance Dovitinib for Colorectal and Pancreas CancerTerminatedNo Results AvailableColorectal Cancer|Pancreas CancerDrug: Dovitinibhttps://ClinicalTrials.gov/show/NCT01888965

* Görseller ve İçerik tekif hakkına sahip olabilir